ZNF280C
gene geneOn this page
Also known as FLJ20095ZNF633ZPET
Summary
ZNF280C (zinc finger protein 280C, HGNC:25955) is a protein-coding gene on chromosome Xq26.1, encoding Zinc finger protein 280C (Q8ND82). May function as a transcription factor.
This gene encodes a member of the zinc finger domain-containing protein family. This family member contains multiple Cys2-His2(C2H2)-type zinc finger domains, the most common type of zinc finger domain that self-folds to form a beta-beta-alpha structure that binds a zinc ion.
Source: NCBI Gene 55609 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 172 total
- MANE Select transcript:
NM_017666
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25955 |
| Approved symbol | ZNF280C |
| Name | zinc finger protein 280C |
| Location | Xq26.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ20095, ZNF633, ZPET |
| Ensembl gene | ENSG00000056277 |
| Ensembl biotype | protein_coding |
| Entrez | 55609 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000370978, ENST00000447817, ENST00000930023
RefSeq mRNA: 1 — MANE Select: NM_017666
NM_017666
CCDS: CCDS14622
Canonical transcript exons
ENST00000370978 — 19 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000676687 | 130230510 | 130230727 |
| ENSE00000676690 | 130239582 | 130239693 |
| ENSE00000869688 | 130215791 | 130216101 |
| ENSE00000869690 | 130220349 | 130220480 |
| ENSE00000869699 | 130236214 | 130236320 |
| ENSE00000869702 | 130243563 | 130243699 |
| ENSE00000869703 | 130243800 | 130243865 |
| ENSE00001267218 | 130205117 | 130205153 |
| ENSE00001267265 | 130236469 | 130236639 |
| ENSE00001321169 | 130246859 | 130247005 |
| ENSE00001342123 | 130260419 | 130260465 |
| ENSE00001342132 | 130268762 | 130268899 |
| ENSE00001599202 | 130205297 | 130205415 |
| ENSE00001645727 | 130228977 | 130229134 |
| ENSE00001677933 | 130209653 | 130209715 |
| ENSE00001718368 | 130227682 | 130227782 |
| ENSE00001772959 | 130226759 | 130226905 |
| ENSE00001933076 | 130202707 | 130204992 |
| ENSE00003791225 | 130215193 | 130215333 |
Expression profiles
Bgee: expression breadth ubiquitous, 179 present calls, max score 97.41.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 10.2767 / max 239.8270, expressed in 1693 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 200475 | 6.8854 | 1595 |
| 200474 | 2.5407 | 1111 |
| 200473 | 0.5581 | 312 |
| 200476 | 0.2924 | 129 |
Top tissues by expression
250 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 97.41 | gold quality |
| oocyte | CL:0000023 | 95.24 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.78 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.30 | gold quality |
| adrenal tissue | UBERON:0018303 | 77.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 75.66 | gold quality |
| ventricular zone | UBERON:0003053 | 75.52 | gold quality |
| calcaneal tendon | UBERON:0003701 | 75.43 | gold quality |
| oviduct epithelium | UBERON:0004804 | 74.96 | gold quality |
| ganglionic eminence | UBERON:0004023 | 74.93 | gold quality |
| cortical plate | UBERON:0005343 | 74.68 | gold quality |
| buccal mucosa cell | CL:0002336 | 74.25 | silver quality |
| corpus epididymis | UBERON:0004359 | 71.87 | gold quality |
| testis | UBERON:0000473 | 70.43 | gold quality |
| bone marrow cell | CL:0002092 | 70.28 | silver quality |
| islet of Langerhans | UBERON:0000006 | 69.51 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 69.46 | gold quality |
| right testis | UBERON:0004534 | 69.22 | gold quality |
| ectocervix | UBERON:0012249 | 68.43 | gold quality |
| endometrium | UBERON:0001295 | 68.37 | gold quality |
| cauda epididymis | UBERON:0004360 | 68.15 | silver quality |
| right adrenal gland cortex | UBERON:0035827 | 67.51 | gold quality |
| endocervix | UBERON:0000458 | 67.47 | gold quality |
| body of uterus | UBERON:0009853 | 67.09 | gold quality |
| colonic epithelium | UBERON:0000397 | 67.07 | silver quality |
| caput epididymis | UBERON:0004358 | 66.90 | silver quality |
| vermiform appendix | UBERON:0001154 | 66.88 | gold quality |
| ovary | UBERON:0000992 | 66.83 | gold quality |
| left testis | UBERON:0004533 | 66.69 | gold quality |
| gastrocnemius | UBERON:0001388 | 66.62 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-109979 | no | 186.21 |
| E-ANND-3 | no | 5.09 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
122 targeting ZNF280C, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-520G-5P | 99.99 | 66.76 | 658 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-MIR-1-3P | 99.93 | 72.35 | 1914 |
| HSA-MIR-206 | 99.93 | 72.50 | 1893 |
| HSA-MIR-4778-3P | 99.93 | 70.40 | 1818 |
| HSA-MIR-5680 | 99.91 | 69.83 | 3421 |
| HSA-MIR-613 | 99.91 | 71.50 | 1710 |
| HSA-MIR-8087 | 99.90 | 69.55 | 1351 |
| HSA-MIR-4493 | 99.90 | 66.48 | 977 |
| HSA-MIR-3686 | 99.90 | 70.53 | 2432 |
| HSA-MIR-380-3P | 99.89 | 70.18 | 1978 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-605-3P | 99.88 | 69.22 | 1833 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
Literature-anchored findings (GeneRIF, showing 2)
- ZPET binds ssDNA and localizes to DNA double-strand breaks (DSBs) and stalled replication forks. (PMID:30567999)
- Zinc finger protein 280C contributes to colorectal tumorigenesis by maintaining epigenetic repression at H3K27me3-marked loci. (PMID:35605119)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp280c | ENSMUSG00000036916 |
| rattus_norvegicus | Zfp280c | ENSRNOG00000006797 |
Paralogs (28): ZBTB25 (ENSG00000089775), PRDM13 (ENSG00000112238), BCL6 (ENSG00000113916), FEZF1 (ENSG00000128610), ZBTB46 (ENSG00000130584), PRDM12 (ENSG00000130711), ZNF280D (ENSG00000137871), NACC2 (ENSG00000148411), FEZF2 (ENSG00000153266), ZBTB7B (ENSG00000160685), NACC1 (ENSG00000160877), BCL6B (ENSG00000161940), GFI1 (ENSG00000162676), GFI1B (ENSG00000165702), ZBTB49 (ENSG00000168826), ZNF280A (ENSG00000169548), ZNF581 (ENSG00000171425), ZNF524 (ENSG00000171443), ZBTB26 (ENSG00000171448), ZBTB21 (ENSG00000173276), ZNF683 (ENSG00000176083), ZBTB33 (ENSG00000177485), ZBTB3 (ENSG00000185670), ZBTB6 (ENSG00000186130), ZBTB14 (ENSG00000198081), ZBTB12 (ENSG00000204366), ZNF580 (ENSG00000213015), ZNF280B (ENSG00000275004)
Protein
Protein identifiers
Zinc finger protein 280C — Q8ND82 (reviewed: Q8ND82)
Alternative names: Suppressor of hairy wing homolog 3, Zinc finger protein 633
All UniProt accessions (2): Q8ND82, Q9UJJ2
UniProt curated annotations — full annotation on UniProt →
Function. May function as a transcription factor.
Subcellular location. Nucleus.
RefSeq proteins (1): NP_060136* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR025243 | DUF4195 | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050527 | ||
| IPR057618 | Znf_POGZ/Z280C-D-like | Domain |
| IPR059074 | Znf-C2H2_Z280C_D | Domain |
Pfam: PF13836, PF25414, PF25429
UniProt features (35 total): cross-link 16, compositionally biased region 6, zinc finger region 5, modified residue 4, region of interest 3, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8ND82-F1 | 60.29 | 0.15 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (20): 80, 223, 227, 540, 5, 10, 14, 33, 55, 75, 113, 126, 167, 174, 180, 187, 273, 522, 564, 574
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 100 (showing top):
GSE45365_NK_CELL_VS_CD8_TCELL_DN, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, HTF_01, DODD_NASOPHARYNGEAL_CARCINOMA_UP, AACTTT_UNKNOWN, CAGCTTT_MIR320, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, HSF1_01, GCAAGAC_MIR431, chrXq26, FORTSCHEGGER_PHF8_TARGETS_UP, RAO_BOUND_BY_SALL4, STK33_DN, STK33_NOMO_DN
GO Biological Process (2): regulation of DNA-templated transcription (GO:0006355), regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
518 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF280C | ADNP2 | Q6IQ32 | 456 |
| ZNF280C | SIAE | Q9HAT2 | 450 |
| ZNF280C | MPHOSPH8 | Q99549 | 448 |
| ZNF280C | OR4D1 | Q15615 | 445 |
| ZNF280C | CRYBG2 | Q8N1P7 | 411 |
| ZNF280C | HEATR4 | Q86WZ0 | 399 |
| ZNF280C | OR4P4 | Q8NGL7 | 398 |
| ZNF280C | NT5DC1 | Q5TFE4 | 383 |
| ZNF280C | NEXMIF | Q5QGS0 | 380 |
| ZNF280C | PCGF6 | Q9BYE7 | 373 |
| ZNF280C | OR4C6 | Q8NH72 | 371 |
| ZNF280C | OR4S2 | Q8NH73 | 371 |
| ZNF280C | TMEM164 | Q5U3C3 | 370 |
| ZNF280C | CWC27 | Q6UX04 | 368 |
| ZNF280C | UHRF2 | Q96PU4 | 355 |
IntAct
59 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CBX1 | ZNF280C | psi-mi:“MI:0915”(physical association) | 0.740 |
| CBX3 | ZNF280C | psi-mi:“MI:0915”(physical association) | 0.740 |
| RAB8B | GDI1 | psi-mi:“MI:0914”(association) | 0.640 |
| ZNF280C | TSPYL2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF280C | psi-mi:“MI:0915”(physical association) | 0.560 | |
| GOLGA2 | ZNF280C | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-6 | ZNF280C | psi-mi:“MI:0915”(physical association) | 0.560 |
| CBX5 | ZNF280C | psi-mi:“MI:0915”(physical association) | 0.560 |
| DAXX | TNRC18 | psi-mi:“MI:0914”(association) | 0.530 |
| CBX1 | ZNF292 | psi-mi:“MI:0914”(association) | 0.530 |
| Cbx1 | psi-mi:“MI:0914”(association) | 0.350 | |
| Bcl7c | SMARCD2 | psi-mi:“MI:0914”(association) | 0.350 |
| ERBB2 | SURF4 | psi-mi:“MI:0914”(association) | 0.350 |
| Prdm16 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| P | psi-mi:“MI:0914”(association) | 0.350 | |
| CBX1 | EXOC5 | psi-mi:“MI:0914”(association) | 0.350 |
| H2AZ1 | SUPT5H | psi-mi:“MI:0914”(association) | 0.350 |
| H2BC21 | SMCHD1 | psi-mi:“MI:0914”(association) | 0.350 |
| HMGA1 | SUPT5H | psi-mi:“MI:0914”(association) | 0.350 |
| HMGN2 | NSD2 | psi-mi:“MI:0914”(association) | 0.350 |
| HMGN5 | SMCHD1 | psi-mi:“MI:0914”(association) | 0.350 |
| NUCKS1 | SMARCA5 | psi-mi:“MI:0914”(association) | 0.350 |
| NUMA1 | SHANK3 | psi-mi:“MI:0914”(association) | 0.350 |
| PHGDH | TIMM44 | psi-mi:“MI:0914”(association) | 0.350 |
| DAXX | SETD1A | psi-mi:“MI:0914”(association) | 0.350 |
| TNFRSF1B | MAP3K7 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF280C | CALML3 | psi-mi:“MI:0914”(association) | 0.350 |
| PHF20L1 | psi-mi:“MI:0914”(association) | 0.350 | |
| CBX3 | MYL12B | psi-mi:“MI:0914”(association) | 0.350 |
| PCM1 | CCDC66 | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (73): ZNF280C (Proximity Label-MS), ZNF280C (Proximity Label-MS), ZNF280C (Affinity Capture-MS), ZNF280C (Affinity Capture-MS), ZNF280C (Affinity Capture-MS), ZNF280C (Proximity Label-MS), ZNF280C (Proximity Label-MS), ZNF280C (Affinity Capture-MS), ZNF280C (Affinity Capture-MS), ZNF280C (Affinity Capture-MS), ZNF280C (Affinity Capture-MS), ZNF280C (Affinity Capture-MS), ZNF280C (Proximity Label-MS), ZNF280C (Affinity Capture-RNA), ZNF280C (Affinity Capture-MS)
ESM2 similar proteins: A0A1L8HTT5, A0JPQ7, A4FV61, A4IFK0, O75151, O88974, P35689, P49140, P55265, P55266, P97432, Q02040, Q0VEE6, Q14202, Q14596, Q15047, Q15554, Q501R9, Q53GL0, Q5EAN7, Q5F3F2, Q5HYC2, Q5R6F3, Q5RC94, Q5RF77, Q5SYB0, Q642B6, Q69Z66, Q69Z99, Q6P3Z3, Q76CY8, Q810L3, Q86XL3, Q8C4S8, Q8ND82, Q8NE31, Q8WY91, Q91VL8, Q95JV5, Q96EP1
Diamond homologs: P59817, Q5PPG4, Q68FE8, Q6N043, Q6P3Y5, Q7Z3K3, Q86YH2, Q8BZH4, Q8ND82, Q99KZ6
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 65 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| heterochromatin formation | 5 | 22.0× | 1e-03 |
| rRNA processing | 5 | 12.2× | 1e-02 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
172 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 48 |
| Likely benign | 9 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2130 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:130205296:CCATT:C | donor_gain | 1.0000 |
| X:130205413:CCC:C | acceptor_gain | 1.0000 |
| X:130205414:CC:C | acceptor_gain | 1.0000 |
| X:130205414:CCC:C | acceptor_gain | 1.0000 |
| X:130205415:CCTA:C | acceptor_gain | 1.0000 |
| X:130209716:C:CC | acceptor_gain | 1.0000 |
| X:130215344:C:CT | acceptor_gain | 1.0000 |
| X:130215345:G:T | acceptor_gain | 1.0000 |
| X:130215941:CTTGT:C | donor_gain | 1.0000 |
| X:130216097:GTAAC:G | acceptor_gain | 1.0000 |
| X:130216102:C:CC | acceptor_gain | 1.0000 |
| X:130220334:C:CA | donor_gain | 1.0000 |
| X:130220340:CAAA:C | donor_gain | 1.0000 |
| X:130220347:A:AC | donor_gain | 1.0000 |
| X:130220348:C:CA | donor_gain | 1.0000 |
| X:130226180:T:C | donor_gain | 1.0000 |
| X:130226753:TCTCA:T | donor_loss | 1.0000 |
| X:130226754:CTCAC:C | donor_loss | 1.0000 |
| X:130226755:TCAC:T | donor_loss | 1.0000 |
| X:130226756:CACCT:C | donor_loss | 1.0000 |
| X:130226757:A:T | donor_loss | 1.0000 |
| X:130226758:C:CA | donor_loss | 1.0000 |
| X:130226903:AACC:A | acceptor_loss | 1.0000 |
| X:130227676:GTGTA:G | donor_loss | 1.0000 |
| X:130227677:TGTAC:T | donor_loss | 1.0000 |
| X:130227678:GTACC:G | donor_loss | 1.0000 |
| X:130227679:TA:T | donor_loss | 1.0000 |
| X:130227680:A:AG | donor_loss | 1.0000 |
| X:130227681:CCT:C | donor_loss | 1.0000 |
| X:130227682:C:A | donor_loss | 1.0000 |
AlphaMissense
4904 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:130220439:A:C | F479L | 1.000 |
| X:130220439:A:T | F479L | 1.000 |
| X:130220440:A:G | F479S | 1.000 |
| X:130220441:A:G | F479L | 1.000 |
| X:130220446:A:G | L477P | 1.000 |
| X:130220462:A:G | C472R | 1.000 |
| X:130226762:A:C | H464Q | 1.000 |
| X:130226762:A:T | H464Q | 1.000 |
| X:130226764:G:C | H464D | 1.000 |
| X:130226774:A:C | H460Q | 1.000 |
| X:130226774:A:T | H460Q | 1.000 |
| X:130226776:G:C | H460D | 1.000 |
| X:130226785:A:C | Y457D | 1.000 |
| X:130226811:A:G | L448P | 1.000 |
| X:130226813:G:C | C447W | 1.000 |
| X:130226814:C:A | C447F | 1.000 |
| X:130226814:C:G | C447S | 1.000 |
| X:130226814:C:T | C447Y | 1.000 |
| X:130226815:A:G | C447R | 1.000 |
| X:130226815:A:T | C447S | 1.000 |
| X:130226816:A:C | F446L | 1.000 |
| X:130226816:A:T | F446L | 1.000 |
| X:130226818:A:G | F446L | 1.000 |
| X:130226822:A:C | C444W | 1.000 |
| X:130226823:C:G | C444S | 1.000 |
| X:130226823:C:T | C444Y | 1.000 |
| X:130226824:A:G | C444R | 1.000 |
| X:130226824:A:T | C444S | 1.000 |
| X:130226826:A:G | L443P | 1.000 |
| X:130226829:A:G | L442S | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000093010 (X:130241959 G>C), RS1000106782 (X:130217405 G>A), RS1000137707 (X:130237031 C>T), RS1000139424 (X:130217129 A>G), RS1000240238 (X:130208899 T>G), RS1000319971 (X:130226808 T>C), RS1000445534 (X:130223808 AAAG>A), RS1000469187 (X:130234783 G>A), RS1000652300 (X:130227261 A>G), RS1000701299 (X:130248135 C>G,T), RS1000702102 (X:130243463 G>A), RS1000767635 (X:130245131 T>C,G), RS1000867756 (X:130270194 G>A), RS1000908408 (X:130251494 A>C), RS1000952740 (X:130203206 A>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008839_319 | Height | 2.000000e-14 |
| GCST90002405_583 | Reticulocyte count | 8.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007986 | reticulocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
36 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression, affects cotreatment, decreases expression | 7 |
| Benzo(a)pyrene | affects methylation, increases methylation, increases mutagenesis | 3 |
| Acetaminophen | increases expression | 2 |
| Air Pollutants | decreases expression, increases abundance, increases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| Particulate Matter | decreases expression, increases abundance, increases expression | 2 |
| FR900359 | affects phosphorylation | 1 |
| TAK-243 | decreases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | increases expression | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| beta-methylcholine | affects expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| tacedinaline | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| Grape Seed Proanthocyanidins | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| jinfukang | decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Leflunomide | increases expression | 1 |
| Panobinostat | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Caffeine | increases phosphorylation | 1 |
| Catechin | affects cotreatment, decreases expression | 1 |
| Clorgyline | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Enzyme Inhibitors | decreases activity, increases O-linked glycosylation | 1 |
| Estradiol | increases expression | 1 |
| Hydroxyurea | decreases expression | 1 |
| Potassium Dichromate | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW28 | HEK293 eGFP-ZNF280C | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.